Nipro Corporation operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nipro with three other
medical equipment manufacturers in Asia:
JMS Co Ltd
sales of 58.06 billion Japanese Yen [US$541.69 million]
of which 67%
was Operating Segment-Japan),
Shandong Weigao Group Medical Polymer Company Ltd
(10.36 billion Chinese Renmimbi [US$1.46 billion]
(599.48 billion Japanese Yen [US$5.59 billion]
of which 55%
was Cardiovascular area business).
During the year ended March of 2019, sales at
Nipro were ¥426.40 billion (US$3.98 billion).
increase of 7.8%
versus 2018, when the company's sales were ¥395.40 billion.
Sales of Pharma Packaging saw an increase
that was more than double the company's growth rate: sales were up
25.1% in 2019, from
¥28.40 billion to ¥35.53 billion.
Not all segments of Nipro experienced an increase in sales in 2019:
sales of Pharmaceutical Business fell 5.0% to ¥63.48 billion.